TrialScientific reports2017

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.

Enrica Cavedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.